Helius Medical Technologies (HSDT) Short Interest Ratio & Short Volume

Short interest is the volume of Helius Medical Technologies shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 52,500 shares of HSDT short. 7.86% of Helius Medical Technologies' shares are currently sold short. Learn More on Helius Medical Technologies' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.86% of Helius Medical Technologies' floating shares are currently sold short.

Helius Medical Technologies saw a decrease in short interest in November. As of November 15th, there was short interest totaling 52,500 shares, a decrease of 21.9% from the previous total of 67,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Helius Medical Technologies currently has issued a total of 710,000 shares. Some of Helius Medical Technologies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Helius Medical Technologies currently has a public float of 668,300 shares.

7.86% of Helius Medical Technologies' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Helius Medical Technologies: Tivic Health Systems, Inc. (59.88%), Nuwellis, Inc. (5.33%), ENDRA Life Sciences Inc. (2.89%), OpGen, Inc. (1.13%), INVO Bioscience, Inc. (40.37%), Revelation Biosciences, Inc. (0.50%), Monopar Therapeutics Inc. (3.14%), Addex Therapeutics Ltd (0.83%), Exicure, Inc. (3.00%), GlucoTrack, Inc. (0.13%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling HSDT is an investing strategy that aims to generate trading profit from Helius Medical Technologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Helius Medical Technologies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HSDT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HSDT, twice per month. The most recent reporting period available is November, 15 2023.